You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atypical chronic myeloid leukemia

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • +3 more
  • based decitabine and olverembatinib（HQP1351)chemotherapy
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jul 24, 2022

      3L+ Therapies Among Chronic Myeloid Leukemia and Those With

      Completed
      • Chronic Myeloid Leukemia
        • East Hanover, New Jersey
          Novartis Investigative Site
        Nov 11, 2022

        Landscape and Real-life Treatment Outcomes in Hungary: Analysis

        Completed
        • Chronic Myeloid Leukaemia
        • Budapest, Hungary
          Pfizer
        Dec 15, 2022

        Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

        Completed
        • Leukemia
        • No Intervention
        • Cambridge, Massachusetts
          Takeda
        Feb 28, 2023

        Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • +3 more
        • Augusta, Georgia
        • +1 more
        Jul 14, 2022

        Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Baltimore, Boston, Columbus (Enasidenib)

        Active, not recruiting
        • Acute Myeloid Leukemia
        • Chronic Myelomonocytic Leukemia
        • Baltimore, Maryland
        • +3 more
        Aug 8, 2022

        MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

        Recruiting
        • Myelodysplastic Syndromes
        • +2 more
        • unrelated umbilical cord blood
        • Nanjing, Jiangsu, China
          The First Affiliated Hospital with Nanjing Medical University
        Oct 16, 2022

        Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Withdrawal;Drug
        • Imatinib withdrawal
        • +2 more
        • Brno, Czechia
        • +7 more
        Aug 24, 2022

        "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

        Not yet recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
          • Sohag, Egypt
            Sohag University Hospital
          Sep 14, 2022

          According to Molecular Identification at Diagnosis

          Not yet recruiting
          • Chronic Myeloid Leukemia
          • Next Generation Sequencing (DNA and RNA)
          • (no location specified)
          Oct 28, 2022

          Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

          Not yet recruiting
          • Chronic Myelogenous Leukemia
          • Houston, Texas
            The University of Texas MD Anderson Cancer Center
          Oct 12, 2023

          Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

          Recruiting
          • Olverembatinib
          • +2 more
          • Shenzhen, Guangdong, China
            Shenzhen Second People's Hospital
          Jul 26, 2022

          Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

          Recruiting
          • Acute Bilineal Leukemia
          • +8 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jan 24, 2023

          sCD62L and SPARC in Chronic Myeloid Leukemia Patients During

          Completed
          • Chronic Myeloid Leukemia
          • ELISA kit
          • Tanta, Egypt
            Tanta University
          May 18, 2022

          Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

          Recruiting
          • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +2 more
          • Laboratory Biomarker Analysis
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jun 15, 2022

          Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

          Recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
          • Dasatinib Pill
          • Ketoconazole Pill
          • Monterrey, Nuevo Leon, Mexico
            Hospital Universitario Dr. José Eleuterio González
          Nov 25, 2022

          Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

          Recruiting
          • Acute Myeloid Leukemia
          • +4 more
          • Recombinant Interleukin-7
          • Houston, Texas
            M D Anderson Cancer Center
          Jan 26, 2023

          Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

          Recruiting
          • Philadelphia Chromosome
          • +4 more
          • Suzhou, Jiangsu, China
            The First Affiliated Hospital of Soochow University
          Jun 23, 2022

          Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

          Recruiting
          • Chronic Myeloid Leukemia in Chronic Phase
          • Shenzhen, Guangdong, China
            Shenzhen Second People's Hospital
          Jul 26, 2022

          Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

          Recruiting
          • Myeloproliferative Neoplasm
          • +2 more
          • Online Mindfulness Meditation
          • Internet-Based Webinars
          • San Francisco, California
            University of California San Francisco
          Aug 9, 2022

          CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

          Not yet recruiting
          • CML (Chronic Myelogenous Leukemia
          • (no location specified)
          Jul 27, 2022

          Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

          Recruiting
          • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • Chronic Phase Chronic Myelogenous Leukemia
          • Text Message-Based Navigation Intervention
          • Survey Administration
          • Philadelphia, Pennsylvania
            Sidney Kimmel Cancer Center at Thomas Jefferson University
          Apr 7, 2022